PACB as of Nov 1 · 09:30 ET
PACBNasdaqLaboratory Analytical Instruments
Pacific Biosciences of California, Inc. · Brief
Next report
3 days
Nov 4 · after closeest.Q3 FY26
Expected move
Inputs2 of 8≥ implied
- avg implied
- ±18.7%
- avg realized
- ±10.2%
Feb 13 '25±17.6%▲+25.00%×1.42
May 8 '25±19.9%▼−6.67%×0.34
Aug 7 '25±20.8%▲+7.14%×0.34
Q3 FY25±14.0%▼−7.05%×0.50
Jan 12 '26±10.9%▲+3.61%×0.33
Feb 12 '26±16.5%▼−7.07%×0.43
Q1 FY26±12.1%▼−14.55%×1.20
Q2 FY26±37.4%▼−10.38%×0.28
quarterimplied−40%0+40%realized×
Q2 FY26±37.4%▼−10.38%×0.28
Q1 FY26±12.1%▼−14.55%×1.20
Feb '26±16.5%▼−7.07%×0.43
Jan '26±10.9%▲+3.61%×0.33
Q3 FY25±14.0%▼−7.05%×0.50
Aug '25±20.8%▲+7.14%×0.34
2 older reports
May '25±19.9%▼−6.67%×0.34
Feb '25±17.6%▲+25.00%×1.42
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 4 report · est.Bull2
+3.86%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
Bear2
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
PACB report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.